Biovie
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -57 | -57 | -57 |
EBITDA | -5,206 | -6,006 | -5,071 |
EBIT | -5,264 | -6,063 | -5,129 |
Net Income | -5,270 | -6,069 | -5,087 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -7,441 | -4,437 | -3,023 |
Cash | 13,098 | 20,540 | 24,978 |
Basic Shares | 7,543 | 7,920 | 5,214 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -229 | -229 | -266 |
EBITDA | -16,980 | -28,997 | -45,726 |
EBIT | -17,209 | -29,226 | -45,955 |
Net Income | -17,542 | -32,120 | -50,255 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -19,025 | -27,945 | -40,252 |
Cash | 17,544 | 23,843 | 19,460 |
Basic Shares | 1,477 | 451 | 324 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.70 |
2026-03-31 | -$0.69 |
2025-12-31 | -$0.76 |
2025-09-30 | -$0.98 |